Non-invasive Cardiac Imaging

Einar HoppGroup leader
Einar Hopp
Group leader

Non-invasive cardiac imaging includes nuclear medicine techniques like SPECT and PET/CT, Computed tomography (CT) and magnetic resonance imaging (MRI). Measurement of metabolism, oxygen demand and perfusion is ever evolving in nuclear medicine, and novel pharmacological agents cause new possibilities and method refinement. Cardiac CT experiencex hardware advances increasing uptake speed and decreasing radiation. Analytic advances include dynamic imaging with functional assessment, and more complex algorithms providing flow estimation. Trends in cardiac MRI include regional function with 4D motion and deformation analyses, and detailed tissue characterization through direct T1, T2 and T2* measurement.Members of the group participate in different clinical projects, providing primary and secondary end points on ischemic heart disease, cardiomyopathies, valvular heart disease and severe heart failure. Imaging studies focus on method development, validation and refinement.

Research projects

  • MR imaging in myocardial infarction after post-conditioning therapy
  • MDCT imaging in the evaluation of coronary arteries in heart transplanted patients
  • Myocardial function in arterial switch-operated patients with transposition of the great arteries
  • MR detection of diffuse myocardial fibrosis in patients with aortic valve stenosis
  • Heart and lung disease in survivors after cancer therapy and/or allogenic stem cell transplantation
  • MRI and PET-CT assessment in candidates for cardiac resynchronisation therapy
  • Detailed MRI morphological analysis and tissue characterization in mitral valve prolaps
  • Assessment of focal and diffuse fibrosis in athletes heart, correlated to arrhythmia

Contact information
Group leader Einar Hopp, Division of Radiology and Nuclear Medicine (KRN), Tel.: 92299629, E-mail: